SHA:600594 Market Cap

SHA:600594 has a market cap or net worth of 3.16 billion as of March 10, 2026. Its market cap has increased by 10.06% in one year.

Market Cap

3.16B

Enterprise Value

3.55B

Revenue

1.91B

Ranking

n/a

PE Ratio

n/a

Stock Price

4.00

Market Cap Chart

Since March 23, 2004, SHA:600594's market cap has increased from 1.79B to 3.16B, an increase of 76.91%. That is a compound annual growth rate of 2.63%.

Market Cap History

Date	Market Cap	% Change
Mar 10, 2026	3.16B	1.26%
Dec 31, 2025	3.12B	11.44%
Dec 31, 2024	2.80B	-37.83%
Dec 29, 2023	4.51B	2.89%
Dec 30, 2022	4.38B	-31.98%
Dec 31, 2021	6.44B	55.75%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ShanXi C&Y Pharmaceutical Group Co.,LTD.	3.18B
Anhui Fengyuan Pharmaceutical	3.10B
Lionco Pharmaceutical Group	3.22B
Ginwa Enterprise (Group)	3.03B
Zhejiang Shengda Bio-Pharm	3.27B
Hainan Shuangcheng Pharmaceuticals	2.97B
Guhan Pharmaceutical Group	2.96B
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	2.95B

Market Cap Rankings